Urokinase for Injection 500000IU Manufacturer, Supplier and PCD Pharma Franchise in India
Taj Pharmaceuticals Ltd. is a leading PAN India manufacturer, exporter, and supplier of Urokinase for Injection 500000IU (UVATAJ). With its world-class manufacturing facilities in Vapi, Gujarat, and corporate presence in Mumbai, Maharashtra, Taj Pharma is among the most trusted names in critical care injectables. Our Urokinase Injection 500000IU is widely recognized for its exceptional purity, high efficacy, and adherence to international quality standards.
As a WHO-GMP and ISO-certified manufacturer, we ensure that every vial of Urokinase for Injection meets global regulatory requirements, making us the preferred supplier across India, Africa, the Middle East, and Latin America.
About Urokinase for Injection 500000IU (UVATAJ)
Urokinase for Injection 500000IU is a sterile, lyophilized thrombolytic agent used for dissolving dangerous blood clots in the bloodstream. It is a life-saving medicine indicated in emergency conditions like pulmonary embolism, heart attack, ischemic stroke, and deep vein thrombosis (DVT).
Key Details:
- Generic Name: Urokinase for Injection
- Brand Name: UVATAJ
- Strength: 500000IU per vial
- Dosage Form: Lyophilized powder for reconstitution
- Route of Administration: Intravenous (IV), under strict medical supervision
- Therapeutic Class: Thrombolytic / Fibrinolytic Agent
Mechanism of Action:
Urokinase works by activating plasminogen to plasmin, which breaks down fibrin clots in the blood vessels. This restores normal blood flow to vital organs, reducing tissue damage and preventing life-threatening complications.
Therapeutic Indications of Urokinase Injection 500000IU
Taj Pharma’s Urokinase for Injection is used in the management of acute and critical cardiovascular emergencies. Major indications include:
- Acute Myocardial Infarction (Heart Attack)
- Dissolves coronary artery clots and improves blood supply to the heart muscle.
- Pulmonary Embolism
- Breaks down clots in pulmonary arteries, preventing respiratory failure.
- Deep Vein Thrombosis (DVT)
- Reduces the risk of pulmonary embolism and chronic venous insufficiency.
- Ischemic Stroke
- Restores blood flow to the brain, minimizing neurological damage.
- Central Venous Catheter Occlusion
- Used in hospital settings to clear blocked catheters.
Advantages of Choosing Taj Pharma for Urokinase Injections
As a top Urokinase injection manufacturer and exporter in India, Taj Pharma offers unmatched benefits for hospitals, distributors, and PCD pharma franchise partners.
1. Global Quality and Regulatory Compliance
- Manufactured in WHO-GMP, ISO, and GLP-certified facilities.
- Sterility, pyrogen, and potency tests ensure safe hospital use.
- International regulatory support for exports to Africa, LATAM, and the Middle East.
2. PAN India and International Supply Chain
- Wide distribution network covering major hospitals and government tenders across India.
- Reliable export solutions with temperature-controlled logistics.
- Bulk manufacturing capabilities to meet large-scale demands.
3. PCD Pharma Franchise and Distribution Opportunities
- Monopoly-based franchise options for distributors and stockists.
- Attractive promotional support and product training.
- Long-term partnership model for business expansion.
Dosage and Administration Guidelines
Urokinase Injection 500000IU should only be administered in hospital settings under the supervision of a trained physician.
- Reconstitution: Dissolve the lyophilized powder using the provided sterile diluent.
- Route of Administration: Intravenous infusion under continuous patient monitoring.
- Dosage: Determined based on patient weight, clot location, and medical history.
- Monitoring:
- Blood coagulation parameters
- Vital signs and bleeding risk
- Imaging studies to confirm clot resolution
Safety and Precautions
Before administering Urokinase for Injection, doctors should evaluate bleeding risk and patient comorbidities.
- Contraindications:
- Active internal bleeding
- History of hemorrhagic stroke
- Recent surgery or trauma
- Use in Pregnancy and Lactation:
- Probably safe during pregnancy but should be used only if prescribed.
- Minimal transfer to breast milk, considered low risk for infants.
- Drug Interactions:
- Avoid concomitant anticoagulants and antiplatelet drugs without medical supervision.
- Alcohol consumption is not recommended during therapy.
Technical Specifications of Urokinase Injection 500000IU
| Parameter | Details |
|---|---|
| Product Name | Urokinase for Injection 500000IU (UVATAJ) |
| Manufacturer | Taj Pharmaceuticals Ltd., Vapi, Gujarat, India |
| Dosage Form | Lyophilized Powder for IV Injection |
| Strength | 500000IU |
| Packing | 1 Vial + Sterile Diluent |
| Route of Administration | Intravenous |
| Therapeutic Use | Thrombolytic / Clot Dissolution |
| Storage | 2°C to 8°C, protect from light |
| Regulatory Compliance | WHO-GMP, ISO, International Quality Standards |
Global Market Presence
Taj Pharma is not only a leading domestic manufacturer but also a recognized exporter of Urokinase Injections worldwide. We have established strong market footprints in:
- Africa: Nigeria, Kenya, South Africa
- Middle East: UAE, Saudi Arabia, Oman
- Latin America (LATAM): Brazil, Peru, Chile
- Southeast Asia: Philippines, Vietnam
Contact Taj Pharma India for Urokinase Injection Supplies
If you are looking for a reliable manufacturer, supplier, or PCD pharma partner for Urokinase Injection 500000IU in India, Taj Pharma India is your trusted source.
📧 Email: info@tajpharma.com
🌍 Website: www.tajpharma.com
📞 Call/WhatsApp: +91 84484 44095
Taj Pharmaceuticals Ltd. continues to be the #1 choice for Urokinase Injection 500000IU manufacturers and suppliers in India. Our commitment to superior quality, timely delivery, and global regulatory compliance ensures life-saving medicines reach patients when they need them most. Whether you are a hospital buyer, distributor, or franchise partner, Taj Pharma guarantees reliability and excellence.
